LABCORP HOLDINGS INC. Operating Lease Right-of-Use Assets
LABCORP HOLDINGS INC. (LH) had Operating Lease Right-of-Use Assets of $803.90 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-02-24
- 2025-12-31: Operating Lease, Right-of-Use Asset $803.90M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $784.50M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $737.10M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $738.10M; Operating Lease, Right-of-Use Asset as first filed $773.60M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-12-31 | $803.90M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $784.50M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $737.10M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $738.10M 10-K · filed 2024-02-26 | $773.60M 10-K · filed 2023-02-28 |
| 2021-12-31 | $746.30M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $789.80M 10-K · filed 2022-02-25 | |
| 2019-12-31 | $732.80M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $681.10M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $770.30M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $717.90M 10-Q · filed 2019-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |